Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inuvair (formoterol + beclometasone) in COPD: effects on airway dimensions
2010-019864-36Phase 3Completed
- Sponsor
- Antwerp University Hospital
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of beclometasone dipropionate + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Antwerp University Hospital. Primary endpoint: Change in central and peripheral airway dimensions (CFD). Started Jun 2010; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-019864-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019864-36.